Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus

Published:2009-05 Issue:5 Volume:11 Page:506-515
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Bosi E.,Dotta F,Jia Y,Goodman M

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2009.01040.x/fullpdf

Reference23 articles.

1. Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications;Consoli;Diabetes Metab,2004

2. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2008

3. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

4. Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet;Halimi;Vasc Health Risk Manag,2008

5. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus;Stumvoll;N Engl J Med,1995

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2024-02-23

2. Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01

3. Initial Combination Therapy in Type 2 Diabetes;Endocrinology and Metabolism;2023-11-30

4. Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study);Diabetes Therapy;2023-07-06

5. Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems;Biomedicines;2023-05-14